Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

NCT03367546 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Study no longer needed

Conditions

Sickle Cell Disease
Thalassemia
High Risk Hematologic Disorders
Cerebral Adrenoleukodystrophy
Inherited Metabolic Disorders

Interventions

PROCEDURE: Blood and Marrow Transplant

Sponsor

Masonic Cancer Center, University of Minnesota